Radius Health to price IPO of 5 million shares at $14.00 to $16.00

Bookrunners Jefferies and Cowen will have greenshoe of 750,000 shares

By Devika Patel

Knoxville, Tenn., April 25 - Radius Health, Inc. will sell 5 million common shares in its initial public offering with a 30-day greenshoe of 750,000 additional shares, according to a Form S-1/A filed Friday with the Securities and Exchange Commission.

The shares will be sold at a price expected to fall between $14.00 and $16.00 per share.

Jefferies and Cowen and Co. will be the joint bookrunners with Canaccord Genuity as the co-lead manager and Cantor Fitzgerald & Co. as co-manager.

Proceeds will be used to fund the clinical development of the company's most advanced product candidates and for other corporate purposes.

The biopharmaceutical company is based in Cambridge, Mass. It has applied to list its common stock on the Nasdaq Global Market under the symbol "RDUS."

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.